Big Pharma Split Corp Class A (PRM) — Financial Flexibility Index
Big Pharma Split Corp Class A (PRM) has a Financial Flexibility Index of -0.07x as of December 2025. Free cash flow of CA$-910.98K (operating CF CA$-910.98K minus capex CA$0.00) represents 0% of total liabilities (CA$13.57 Million). Check Big Pharma Split Corp Class A investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Big Pharma Split Corp Class A Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Big Pharma Split Corp Class A across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Big Pharma Split Corp Class A generate cash.
Annual Financial Flexibility Index for Big Pharma Split Corp Class A (2017–2025)
Year-by-year free cash flow to debt coverage for Big Pharma Split Corp Class A. Explore PRM operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.08x | CA$-1.06 Million | CA$-1.06 Million | CA$13.57 Million | ▲ +24.3% |
| 2024 | -0.10x | CA$-1.30 Million | CA$-1.30 Million | CA$12.62 Million | ▼ -109.2% |
| 2023 | 1.11x | CA$11.86 Million | CA$11.86 Million | CA$10.68 Million | ▲ +1804.8% |
| 2022 | 0.06x | CA$1.13 Million | CA$1.13 Million | CA$19.37 Million | ▲ +110.0% |
| 2021 | -0.58x | CA$-9.00 Million | CA$-9.00 Million | CA$15.41 Million | ▼ -230.9% |
| 2020 | 0.45x | CA$4.35 Million | CA$4.35 Million | CA$9.75 Million | ▼ -44.1% |
| 2019 | 0.80x | CA$8.68 Million | CA$8.68 Million | CA$10.87 Million | ▲ +829.5% |
| 2018 | 0.09x | CA$1.27 Million | CA$1.27 Million | CA$14.79 Million | ▲ +103.8% |
| 2017 | -2.24x | CA$-30.95 Million | CA$-30.95 Million | CA$13.81 Million | — |